Related Experiment Video
Updated: Jan 7, 2026

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
Published on: June 16, 2023
Estimating the Value of Combination Vaccines: A Methodological Framework.
Mark Jit1, Allison Portnoy2, Clint Pecenka3
1Department of Global and Environmental Health, School of Global Public Health, New York University, New York, NY, USA. mark.jit@nyu.edu.
Combination vaccines offer public health benefits but require economic evaluation. A new framework captures their value through caregiver cost savings, system efficiencies, and streamlined schedules.
Area of Science:
- Vaccinology
- Health Economics
- Public Health Policy
Background:
- Combination vaccines integrate multiple antigens into a single administration, offering programmatic advantages for crowded immunization schedules.
- Despite benefits, higher development costs and unclear market signals can deter manufacturer investment in combination vaccines.
- Existing health economic evaluation frameworks may not fully capture the multifaceted value of combination vaccines.
Purpose of the Study:
- To propose a comprehensive framework for evaluating the economic value of combination vaccines.
- To demonstrate how this framework can inform investment decisions for new vaccine introductions.
- To highlight the need for data collection to support real-world application of the framework.
Main Methods:
- Developed a four-domain framework to capture the value of combination vaccines: caregiver cost reductions, health system operational efficiencies, opportunity costs of schedule slots, and schedule streamlining.
- Applied the framework to a hypothetical vaccine introduction scenario, comparing standalone, replacement, and combination product formulations.
- Considered the value of reducing administrations for standalone vaccines.
Main Results:
- The proposed framework quantifies benefits beyond direct medical costs, including tangible/intangible caregiver costs and health system efficiencies.
- Comparing introduction scenarios revealed distinct value propositions for standalone versus combination vaccine products.
- The framework's practicality was demonstrated through a hypothetical case study.
Conclusions:
- A comprehensive economic evaluation framework is crucial for accurately assessing the value of combination vaccines.
- Capturing caregiver savings, operational efficiencies, and schedule benefits is essential for guiding vaccine investment decisions.
- Further data collection on existing vaccine values and willingness-to-pay for fewer administrations will enhance framework application.
More Related Videos
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
11:07Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
Related Concept Videos
Vaccinations
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses